Research nieuws

Research nieuws

Patricia Bruijning-Verhagen appointed professor of vaccination and infection control epidemiology

Portrait picture of Patricia Bruijning, professor of vaccination and infection control epidemiology

Utrecht University and UMC Utrecht have announced the appointment of Patricia Bruijning-Verhagen as professor of vaccination and infection control epidemiology, effective June 1, 2024. This position will enable Patricia to continue her work in designing and evaluating optimal infection prevention policies through vaccination and other innovative strategies. Her appointment comes at a crucial time, as the world faces the dual challenge of emerging infectious diseases and an expanding portfolio of vaccines.

Read more

Kidney tumors in children: specific diagnosis with MRI

Researcher Justine van der Beek with her publication in front of the WKZ.

Justine van der Beek researched how different types of kidney tumors can be distinguished using MRI scans.

Read more

World-class collaboration receives €37.5 million for regenerative medicine using smart materials

Researcher with a pincet and test tube.

Read more

Study of new treatment for severe influenza pneumonia

Van elke vijf patiënten die met ernstige longontsteking door influenza op de intensive care (IC) worden opgenomen, overlijdt er gemiddeld één. Om dit relatief hoge risico op overlijden te verlagen, gaan Nederlandse onderzoekers onder leiding van UMC Utrecht geneesmiddelen die eerder succesvol waren bij de behandeling van patiënten met ernstige Covid-19 op de IC terecht kwamen, nu ook onderzoeken bij IC-patiënten met ernstige longontsteking door influenza. ZonMw heeft voor deze studie een subsidie van ruim € 2.1 miljoen beschikbaar gesteld.

Read more

Sabine Fuchs appointed professor

Portrait picture of Sabine Fuchs, professor of Metabolic diseases and innovative therapies at the UMC Utrecht.

How do we improve care for patients with rare diseases for which there are currently no treatments? This question is central to the work of pediatrician Sabine Fuchs. She has been appointed professor of Metabolic diseases and innovative therapies at the UMC Utrecht as of April 15, 2024. ‘I want to make these types of diseases treatable by also focusing on the other organs.’

Read more

Grant for research teams UMC Utrecht from ZonMw Open Competition

Researcher in a lab.

Five research teams of the UMC Utrecht receive a grant for projects in the framework of the ZonMw Open Competition. With this funding, the research teams can develop innovative team science initiatives that contribute to innovation within fundamental (bio)medical science and long-term health care. Within all projects, the research teams collaborate with other knowledge institutions. A total of 29 projects were honored for an amount of 23 million euros.

Read more

UMC Utrecht and Philips speed up development of image-guided treatments

UMC Utrecht and Philips are bringing together healthcare professionals, researchers and technicians in a 'fieldlab'. Here, they will develop new innovative technology and software to benefit healthcare. The goal is to devise less burdensome and more efficient treatments for patients, while at the same time realizing a more sustainable healthcare system.

Read more

New study speeds up radiation therapy

Nurses preparing a patient for treatment in the MR-Linac

A targeted radiation therapy that lasts only 15 minutes, instead of 45 minutes. Plus: an even more precise, real-time treatment of the tumor. These are the two goals of a new study by UMC Utrecht to further innovate the MR-Linac. NWO has granted 1.7 million euros to this research project.

Read more

Four new cancer research projects at UMC Utrecht receive Hanarth grants

How can artificial intelligence be used to improve treatment in cancer patients? Researchers from UMC Utrecht are working on this question. Four research projects at UMC Utrecht received funding for this from the Hanarth Fonds.

Read more

GRIPonMASH received significant EU funding to improve prevention and care of Metabolic dysfunction-Associated SteatoHepatitis (MASH)

GRIPonMASH, a newly founded consortium consisting of 27 European institutions and companies, has bundled resources to bring about a transformational change in the detection and treatment of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD). Supported by the Innovative Health Initiative Joint Undertaking (IHI JU), the consortium will focus on developing the GRIPonMASH Diagnostic Platform which will allow early detection of patients with MASH, better patient stratification and personalized lifestyle advice.

Read more

Working at UMC Utrecht





Practical uses cookies

This website uses cookies This website displays videos from, among others, YouTube. Such parties place cookies (third-party cookies). If you do not want these cookies, you can indicate that here. We also place cookies ourselves to improve our site.

Read more about the cookie policy

Agree No, rather not